242 related articles for article (PubMed ID: 31432600)
21. Extracellular Matrix Components Regulate Bone Sialoprotein Expression in MDA-MB-231 Breast Cancer Cells.
Keller F; Bruch R; Clauder F; Hafner M; Rudolf R
Cells; 2021 May; 10(6):. PubMed ID: 34073955
[TBL] [Abstract][Full Text] [Related]
22. Expression of bone sialoprotein in primary human breast cancer is associated with poor survival.
Bellahcène A; Menard S; Bufalino R; Moreau L; Castronovo V
Int J Cancer; 1996 Aug; 69(4):350-3. PubMed ID: 8797881
[TBL] [Abstract][Full Text] [Related]
23. CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3-ERK1/2-dependent S100A4-upregulated pathway.
Chen PS; Wang MY; Wu SN; Su JL; Hong CC; Chuang SE; Chen MW; Hua KT; Wu YL; Cha ST; Babu MS; Chen CN; Lee PH; Chang KJ; Kuo ML
J Cell Sci; 2007 Jun; 120(Pt 12):2053-65. PubMed ID: 17550972
[TBL] [Abstract][Full Text] [Related]
24. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling.
Luo J; Yao JF; Deng XF; Zheng XD; Jia M; Wang YQ; Huang Y; Zhu JH
J Exp Clin Cancer Res; 2018 Feb; 37(1):23. PubMed ID: 29426357
[TBL] [Abstract][Full Text] [Related]
25. Exosomal miR-19a and IBSP cooperate to induce osteolytic bone metastasis of estrogen receptor-positive breast cancer.
Wu K; Feng J; Lyu F; Xing F; Sharma S; Liu Y; Wu SY; Zhao D; Tyagi A; Deshpande RP; Pei X; Ruiz MG; Takahashi H; Tsuzuki S; Kimura T; Mo YY; Shiozawa Y; Singh R; Watabe K
Nat Commun; 2021 Aug; 12(1):5196. PubMed ID: 34465793
[TBL] [Abstract][Full Text] [Related]
26. Cyclin D1b Splice Variant Promotes αvβ3-mediated EMT Induced by LPS in Breast Cancer Cells.
Luo BP; Luo J; Hu YB; Yao XW; Wu FH
Curr Med Sci; 2018 Jun; 38(3):467-472. PubMed ID: 30074214
[TBL] [Abstract][Full Text] [Related]
27. Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis.
Diel IJ; Solomayer EF; Seibel MJ; Pfeilschifter J; Maisenbacher H; Gollan C; Pecherstorfer M; Conradi R; Kehr G; Boehm E; Armbruster FP; Bastert G
Clin Cancer Res; 1999 Dec; 5(12):3914-9. PubMed ID: 10632320
[TBL] [Abstract][Full Text] [Related]
28. The type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by alphaVbeta3 integrin in human breast cancer cells.
Borrirukwanit K; Lafleur MA; Mercuri FA; Blick T; Price JT; Fridman R; Pereira JJ; Leardkamonkarn V; Thompson EW
Matrix Biol; 2007 May; 26(4):291-305. PubMed ID: 17175151
[TBL] [Abstract][Full Text] [Related]
29. Bone sialoprotein promotes bone metastasis of a non-bone-seeking clone of human breast cancer cells.
Zhang JH; Wang J; Tang J; Barnett B; Dickson J; Hahsimoto N; Williams P; Ma W; Zheng W; Yoneda T; Pageau S; Chen J
Anticancer Res; 2004; 24(3a):1361-8. PubMed ID: 15274296
[TBL] [Abstract][Full Text] [Related]
30. Sustained delivery and efficacy of polymeric nanoparticles containing osteopontin and bone sialoprotein antisenses in rats with breast cancer bone metastasis.
Elazar V; Adwan H; Bäuerle T; Rohekar K; Golomb G; Berger MR
Int J Cancer; 2010 Apr; 126(7):1749-60. PubMed ID: 19739076
[TBL] [Abstract][Full Text] [Related]
31. Osteopontin knockdown inhibits αv,β3 integrin-induced cell migration and invasion and promotes apoptosis of breast cancer cells by inducing autophagy and inactivating the PI3K/Akt/mTOR pathway.
Zhang H; Guo M; Chen JH; Wang Z; Du XF; Liu PX; Li WH
Cell Physiol Biochem; 2014; 33(4):991-1002. PubMed ID: 24714122
[TBL] [Abstract][Full Text] [Related]
32. Expression of bone matrix proteins in human breast cancer: potential roles in microcalcification formation and in the genesis of bone metastases.
Bellahcène A; Castronovo V
Bull Cancer; 1997 Jan; 84(1):17-24. PubMed ID: 9180854
[TBL] [Abstract][Full Text] [Related]
33. Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells.
Rolli M; Fransvea E; Pilch J; Saven A; Felding-Habermann B
Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9482-7. PubMed ID: 12874388
[TBL] [Abstract][Full Text] [Related]
34. Decreased levels of osteopontin and bone sialoprotein II are correlated with reduced proliferation, colony formation, and migration of GFP-MDA-MB-231 cells.
Adwan H; Bäuerle T; Najajreh Y; Elazer V; Golomb G; Berger MR
Int J Oncol; 2004 May; 24(5):1235-44. PubMed ID: 15067347
[TBL] [Abstract][Full Text] [Related]
35. The role of the SIBLING, Bone Sialoprotein in skeletal biology - Contribution of mouse experimental genetics.
Bouleftour W; Juignet L; Bouet G; Granito RN; Vanden-Bossche A; Laroche N; Aubin JE; Lafage-Proust MH; Vico L; Malaval L
Matrix Biol; 2016; 52-54():60-77. PubMed ID: 26763578
[TBL] [Abstract][Full Text] [Related]
36. Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins.
Sung V; Stubbs JT; Fisher L; Aaron AD; Thompson EW
J Cell Physiol; 1998 Sep; 176(3):482-94. PubMed ID: 9699501
[TBL] [Abstract][Full Text] [Related]
37. Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls metastasis of breast cancer cells to bone.
Leblanc R; Lee SC; David M; Bordet JC; Norman DD; Patil R; Miller D; Sahay D; Ribeiro J; Clézardin P; Tigyi GJ; Peyruchaud O
Blood; 2014 Nov; 124(20):3141-50. PubMed ID: 25277122
[TBL] [Abstract][Full Text] [Related]
38. Cyclin D1b splice variant promotes αvβ3-mediated adhesion and invasive migration of breast cancer cells.
Wu FH; Luo LQ; Liu Y; Zhan QX; Luo C; Luo J; Zhang GM; Feng ZH
Cancer Lett; 2014 Dec; 355(1):159-67. PubMed ID: 25193465
[TBL] [Abstract][Full Text] [Related]
39. Bone sialoprotein enhances migration of bone marrow stromal cells through matrices by bridging MMP-2 to alpha(v)beta3-integrin.
Karadag A; Fisher LW
J Bone Miner Res; 2006 Oct; 21(10):1627-36. PubMed ID: 16995818
[TBL] [Abstract][Full Text] [Related]
40. Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells.
Taipaleenmäki H; Farina NH; van Wijnen AJ; Stein JL; Hesse E; Stein GS; Lian JB
Oncotarget; 2016 Nov; 7(48):79032-79046. PubMed ID: 27738322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]